Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test.

Xie, Xuping; Nielsen, Marisa C; Muruato, Antonio E; Fontes-Garfias, Camila R; Ren, Ping

Xie, Xuping; Nielsen, Marisa C; Muruato, Antonio E; Fontes-Garfias, Camila R; Ren, Ping.

Afiliación

Xie X; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Nielsen MC; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Muruato AE; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Fontes-Garfias CR; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Ren P; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: piren@UTMB.edu.

Diagn Microbiol Infect Dis ; 99(2): 115248, 2021 Feb.

Article en En | MEDLINE | ID: mdl-33130510

Asunto(s)

Anticuerpos Antivirales/sangre; COVID-19/diagnóstico; Pruebas de Neutralización/métodos; SARS-CoV-2/inmunología; Ensayo de Placa Viral/métodos; Humanos; Inmunoensayo/métodos; Inmunoglobulina G/sangre; Inmunoglobulina M/sangre; Pruebas en el Punto de Atención

Palabras clave

IgG; IgM; SARS-CoV-2; lateral flow assay; plaque reduction neutralization test

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ensayo de Placa Viral / Pruebas de Neutralización / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies / Evaluation_studies Límite: Humans Idioma: En Revista: Diagn Microbiol Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google